Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Xilio Therapeutics Inc., 3 years.
Xilio Therapeutics Inc.
Director
Latigo Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Insmed Incorporated | Open-market sale | −2,404 | $102.27 | $245,857 |
| May 13, 2026 | Insmed Incorporated | Open-market sale | −8,272 | $116.18 | $961,041 |
| Feb 3, 2026 | Insmed Incorporated | Open-market sale | −748 | $156.34 | $116,942 |
| Jan 8, 2026 | Insmed Incorporated | Open-market sale | −1,447 | $174.17 | $252,024 |
| Jan 7, 2026 | Insmed Incorporated | Open-market sale | −1,678 | $175.07 | $293,767 |
| Jan 6, 2026 | Insmed Incorporated | Open-market sale | −1,517 | $173.33 | $262,942 |
| Jan 2, 2026 | Insmed Incorporated | Grant or award | +5,998 | — | — |
| Jan 2, 2026 | Insmed Incorporated | Grant or award | +5,645 | — | — |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +3,443 | $26.46 | $91,102 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +11,455 | $28.88 | $330,820 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +15,890 | $29.13 | $462,876 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +17,100 | $34.03 | $581,913 |
| Jul 21, 2025 | Insmed Incorporated | Open-market sale | −32,090 | $102.38 | $3,285,374 |
| Jul 21, 2025 | Insmed Incorporated | Open-market sale | −26,310 | $103.03 | $2,710,719 |
| Jul 7, 2025 | Insmed Incorporated | Option exercise | +6,244 | $19.74 | $123,257 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.